These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 34152572)
1. Association of metabolic syndrome with cardiovascular outcomes in hypertensive patients: a systematic review and meta-analysis. Liu J; Chen Y; Cai K; Gong Y J Endocrinol Invest; 2021 Nov; 44(11):2333-2340. PubMed ID: 34152572 [TBL] [Abstract][Full Text] [Related]
2. Association of Metabolic Syndrome with Adverse Outcomes in Patients with Stable Coronary Artery Disease: A Meta-Analysis. Su Y; Zhang X Horm Metab Res; 2023 Feb; 55(2):96-102. PubMed ID: 36113500 [TBL] [Abstract][Full Text] [Related]
3. Is Metabolic Syndrome Associated with the Risk of Recurrent Stroke: A Meta-Analysis of Cohort Studies. Li X; Li X; Fang F; Fu X; Lin H; Gao Q J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2700-2705. PubMed ID: 29050848 [TBL] [Abstract][Full Text] [Related]
4. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C; Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691 [TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA. Gupta AK; Dahlof B; Sever PS; Poulter NR; Diabetes Care; 2010 Jul; 33(7):1647-51. PubMed ID: 20413525 [TBL] [Abstract][Full Text] [Related]
7. ASSOCIATION OF RETINAL VEIN OCCLUSION WITH CARDIOVASCULAR EVENTS AND MORTALITY: A Systematic Review and Meta-analysis. Wu CY; Riangwiwat T; Limpruttidham N; Rattanawong P; Rosen RB; Deobhakta A Retina; 2019 Sep; 39(9):1635-1645. PubMed ID: 30829987 [TBL] [Abstract][Full Text] [Related]
8. Association Between Metabolic Syndrome and All-Cause Mortality in Patients with Acute Coronary Syndrome: A Meta-Analysis. Yang Y; Shen H; Jin Z; Ma D; Zhao Q; Zhang X Horm Metab Res; 2021 Apr; 53(4):257-263. PubMed ID: 33694137 [TBL] [Abstract][Full Text] [Related]
9. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Solbu MD; Kronborg J; Jenssen TG; Njølstad I; Løchen ML; Mathiesen EB; Wilsgaard T; Eriksen BO; Toft I Atherosclerosis; 2009 Jun; 204(2):503-8. PubMed ID: 19091314 [TBL] [Abstract][Full Text] [Related]
10. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons. Park S; Lee S; Kim Y; Lee Y; Kang MW; Han K; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK Ann Intern Med; 2019 Dec; 171(12):875-884. PubMed ID: 31766057 [TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome and Cardiovascular Risk in Elderly Treated Hypertensive Patients. Pierdomenico SD; Pierdomenico AM; Di Tommaso R; Coccina F; Di Carlo S; Cuccurullo F; Porreca E Am J Hypertens; 2016 Mar; 29(3):365-71. PubMed ID: 26224400 [TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies. Li X; Li X; Lin H; Fu X; Lin W; Li M; Zeng X; Gao Q J Clin Neurosci; 2017 Jun; 40():34-38. PubMed ID: 28268148 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Prognosis for Patients with Metabolic Syndrome after Recanalization Therapy for Stroke. Kern I; Šupe S; Ljevak J; Starčević K; Poljakovic Z Metab Syndr Relat Disord; 2020 Nov; 18(9):419-425. PubMed ID: 32936042 [No Abstract] [Full Text] [Related]
14. Influence of Metabolic Syndrome on the Long-Term Prognosis of Patients with Myocardial Infarction: A Meta-Analysis. Chen T; Shi Z; Qian C Horm Metab Res; 2024 Jun; 56(6):435-444. PubMed ID: 38056496 [TBL] [Abstract][Full Text] [Related]
15. Association of serum uric acid with mortality and cardiovascular outcomes in patients with hypertension: a meta-analysis. Yang Y; Zhang X; Jin Z; Zhao Q J Thromb Thrombolysis; 2021 Nov; 52(4):1084-1093. PubMed ID: 33966143 [TBL] [Abstract][Full Text] [Related]
16. Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Dungan K; Craven TE; Soe K; Wright JT; Basile J; Haley WE; Kressin NR; Rani U; Tamariz L; Whittle J; Wiggers A; Osei K Diabetes Obes Metab; 2018 Mar; 20(3):629-637. PubMed ID: 29024310 [TBL] [Abstract][Full Text] [Related]
17. Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation. Lovic MB; Djordjevic DB; Tasic IS; Nedeljkovic IP Hellenic J Cardiol; 2018; 59(4):226-231. PubMed ID: 29452307 [TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction. Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207 [TBL] [Abstract][Full Text] [Related]
19. Association of microalbuminuria and adverse outcomes in hypertensive patients: a meta-analysis. Hong Z; Jiang Y; Liu P; Zhang L Int Urol Nephrol; 2021 Nov; 53(11):2311-2319. PubMed ID: 33674949 [TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and liver-related events: a systematic review and meta-analysis. Ren H; Wang J; Gao Y; Yang F; Huang W BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]